On July 4th, the 15th China Pharmaceutical Industry Development Summit Forum and Harbin New Area Promotion Conference, jointly hosted by the All-China Federation of Industry and Commerce Medical and Pharmaceutical Industry Chamber, Heilongjiang Provincial Federation of Industry and Commerce, and Heilongjiang Provincial Development and Reform Commission, was held in Harbin.

This conference solemnly unveiled 12 rankings. With solid pharmaceutical research and development capabilities and high standard service levels, Leadingpharm has won the top three of the Top 50 Chinese Pharmaceutical Research and Development Enterprises and Pharmaceutical Industry Law abiding and Honest Enterprise of China for many consecutive years.

The conference solemnly unveiled 12 rankings. Leadingpharm, with its solid pharmaceutical research and development capabilities and high standard service levels, has won the top three of the Top 50 Chinese Pharmaceutical Research and Development Enterprises, Law abiding and Honest Enterprise in the Chinese Pharmaceutical Industry and other honors for consecutive years.
 

Mr. Wallace Tao, Chairman of Leadingpharm, was invited to participate in the 15th China Pharmaceutical Industry Development Summit Forum Entrepreneur Summit Dialogue. Together with pharmaceutical industry entrepreneurs, he shared his experience and accumulation in enterprise development from multiple perspectives such as regulation, innovative research and development, centralized procurement layout, sales terminals, and traditional Chinese medicine quality, and explored new directions for the development of China's pharmaceutical industry with the Chamber of Commerce platform as the core.

The uncertainty and globalization challenges in the pharmaceutical industry still exist. We must be vigilant against unpredictable market changes, maintain tracking of market dynamics, fully utilize the tools of open cooperation between government, industry, academia, research and application, and truly establish a new pattern of pharmaceutical innovation industry guided by unmet clinical needs, with higher concentration, healthy competition, and sustainable development.

Based on a strong team of experts, technological advantages, and a sound quality management system, Leadingpharm continuously overcomes high-end formulation technology barriers, solves bottleneck problems, and promotes the development of China's pharmaceutical industry to a higher level. In the future, Leadingpharm will continue to improve its innovation capabilities, face challenges, seize opportunities, deepen cooperation with pharmaceutical colleagues, and work together to help build a Healthy China.